← All diseases Brain and nervous system

Multiple sclerosis (progressive)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (104)Meta-analysis (24)Treatment guideline (1)Randomized trial (43)Systematic review (21)Phase 3 Study (15)Clinical trial (370)Review article (234)Early study (phase 1 or 2) (22)Case report (83)Laboratory or animal study (21)Commentary or editorial (19) Studies currently recruiting participants only (33)

Filter

Publications and studies (1542)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MicroRNA frontiers: Illuminating early detection paths in multiple sclerosis. (2025/03/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis. (2025/02/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A review on multiple sclerosis: Unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations. (2025/02/16) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. IgLON5 autoimmunity secondary to immune checkpoint inhibitor. (2025/02/15) ♡
• 2-[(18)F] FDG PET/CT in Rapid Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency: A Case Report. (2025/02/12) ♡
• Endogenous Ketone Bodies Are Associated with Metabolic Vulnerability and Disability in Multiple Sclerosis. (2025/02/11) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: A severe myositis mimicking bulbar palsy after administration of immune checkpoint inhibitors. (2025/02/10) ♡
• snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses. (2025/02/05) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases. (2025/02/04) ♡
• Combination among VEP, OCT and TCD data in patients with relapsing-remitting multiple sclerosis during attack-free period. (2025/02/01) ♡
• Optical coherence tomography in multiple sclerosis: A Tunisian tertiary center study. (2025/02/01) ♡
• AKRs confer oligodendrocytes resistance to differentiation-stimulated ferroptosis. (2025/02/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Sportizumab - Multimodal progressive exercise over 10 weeks decreases Th17 frequency and CD49d expression on CD8(+) T cells in relapsing-remitting multiple sclerosis: A randomized controlled trial. (2025/02/01) ♡
• Girdin deficiency causes developmental and epileptic encephalopathy with hippocampal sclerosis and interneuronopathy. (2025/02/01) ♡
• Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis. (2025/02/01) ♡
• The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White Americans. (2025/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real-world infection risk in multiple sclerosis patients on long-term immunomodulatory treatments. (2025/02/01) ♡
• Assessment of dysphagia and its associations in patients with secondary progressive multiple sclerosis. (2025/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic targeting of obesity-induced neuroinflammation and neurodegeneration. (2025/01/17) ♡
• Urethral bulking agents and pelvic floor muscle training for the treatment of stress urinary incontinence in female patients with multiple sclerosis. (2025/01/17) ♡
• Ofatumumab for multiple sclerosis with disability accumulation. (2025/01/15) ♡
• Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease: Analysis of the PRECEPT and DATATOP Trial Datasets. (2025/01/14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis. (2025/01/14) ♡
• Hyperintense lesions of the middle cerebellar peduncle and beyond: a pictorial essay. (2025/01/10) ♡
• Immune response profiling of HERV-W envelope proteins in multiple sclerosis: potential biomarkers for disease progression. (2025/01/09) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Pilot functional magnetic resonance imaging study of clemastine-aided functional recovery on a mouse model of demyelination. (2025/01/07) ♡
• Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile study. (2025/01/06) ♡
• Pediatric, adult, and late-onset multiple sclerosis patients: A unified analysis of clinical profiles and treatment responses. (2025/01/01) ♡
• Association between education level and disability progression in patients with multiple sclerosis in France. (2025/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosis. (2025/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. COVID-19 in patients with multiple sclerosis-A narrative review. (2025/01/01) ♡
• Hematological markers as prognostic indicators in multiple sclerosis progression. (2025/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Revisiting the role of sexual hormones in the demyelinated central nervous system. (2025/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Neurofilament Light Chain as a Discriminator of Disease Activity Status in MOG Antibody-Associated Disease. (2025/01/01) ♡
• Assessing disability progression using the WHODAS 2.0 in multiple sclerosis: Investigating clinical and socio-demographic factors in a large longitudinal cohort study (TONiC-MS). (2025/01/01) ♡
• Tumour necrosis factor-like weak inducer of apoptosis participates in the development of cutaneous fibrosis in an experimental systemic sclerosis model. (2025/01/01) ♡
• Exploring the Potential of Immersive Virtual Reality (VR) as a tool to enhance cognitive functions and alleviate clinical symptoms in Multiple Sclerosis (MS): Enhancing Cognitive Functions in Multiple Sclerosis Using Virtual Reality. (2025/01/01) ♡
• Evaluation of myelin content in the spinal cord of patients with multiple sclerosis: A positron emission tomography study. (2025/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New potential ligand-receptor axis involved in tissue repair as therapeutic targets in progressive multiple sclerosis. (2025/01/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Coenzyme Q10 supplementation in multiple sclerosis; A systematic review. (2025/01/01) ♡
• Comparison of practice-related changes in dual task walking performance and neural efficiency between older adults with progressive and relapsing-remitting multiple sclerosis. (2025/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications. (2025/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis (2025-12-31) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland) (2025-12-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis. (2025-12-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Senolytics for Secondary Progressive MS (2025-12-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active Disease (2025-12-04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Libyan Multiple Sclerosis Registry Study (2025-12-04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen (2025-11-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis (2025-11-19) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.